Report cover image

Global Pharmaceutical Hydrogenated Soybean Oil Market Growth 2025-2031

Published Aug 14, 2025
Length 93 Pages
SKU # LPI20312602

Description

The global Pharmaceutical Hydrogenated Soybean Oil market size is predicted to grow from US$ 89.3 million in 2025 to US$ 114 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Pharmaceutical grade hydrogenated soybean oil is a pharmaceutical excipient made from soybean oil through refining, decolorization, hydrogenation and deodorization. It is a white to light yellow block or powder. After heating, it becomes a transparent light yellow liquid. It is easily soluble in dichloromethane or toluene, but insoluble in water and ethanol. This product is widely used in pharmaceutical preparations due to its good stability, lubricity and biocompatibility.

United States market for Pharmaceutical Hydrogenated Soybean Oil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Pharmaceutical Hydrogenated Soybean Oil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Pharmaceutical Hydrogenated Soybean Oil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Pharmaceutical Hydrogenated Soybean Oil players cover ADM, ABITEC, Aria Ingredients, Jiangxi Alpha Hi-Tech Pharmaceutical, Xi'an Tianzheng Pharmaceutical Excipients, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Hydrogenated Soybean Oil Industry Forecast” looks at past sales and reviews total world Pharmaceutical Hydrogenated Soybean Oil sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Hydrogenated Soybean Oil sales for 2025 through 2031. With Pharmaceutical Hydrogenated Soybean Oil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Hydrogenated Soybean Oil industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Hydrogenated Soybean Oil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Hydrogenated Soybean Oil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Hydrogenated Soybean Oil market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Hydrogenated Soybean Oil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Hydrogenated Soybean Oil.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Hydrogenated Soybean Oil market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Bulk
Powder

Segmentation by Application:
Tablet Lubricant
Capsule Filler
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ADM
ABITEC
Aria Ingredients
Jiangxi Alpha Hi-Tech Pharmaceutical
Xi'an Tianzheng Pharmaceutical Excipients
Qidong Huatuo Pharmaceutical
Shanxi Jinyang Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Hydrogenated Soybean Oil market?

What factors are driving Pharmaceutical Hydrogenated Soybean Oil market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Hydrogenated Soybean Oil market opportunities vary by end market size?

How does Pharmaceutical Hydrogenated Soybean Oil break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

93 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Pharmaceutical Hydrogenated Soybean Oil by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Pharmaceutical Hydrogenated Soybean Oil by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.